Vapourtec has launched a video which demonstrates fully automated solid phase peptide synthesis using its patented automatic Variable Bed Flow Reactor (VBFR).
The process begins with swelling Tentagel S resin in DMF, preheating and Fmoc deprotection using 20% Piperidine in DMF. A reduction in resin volume marks the deprotection step, tracked on the VBFR’s volume graph and detected by UV at 365 nm, producing a distinct Fmoc peak.
Following deprotection, activated amino acids (AAs) are introduced, causing the resin volume to expand. This step is visualised by a darker orange slug travelling through the resin. The reagents flow through the resin in a single pass only, rather than traditional recirculation.
Vapourtec’s single-pass process is designed to produce higher-purity crude peptides. The VBFR’s automated system manages repeated cycles of Fmoc deprotection and AA coupling, elongating the peptide chain while maintaining precise control over the resin to ensure there is no channelling or dilution of reagents.
The video demonstrates the instrument’s ability to identify and mitigate aggregation events. GLP-1 sequence aggregation is identified during the coupling of F and E amino acids. By operating at elevated temperatures and maintaining a controlled environment, the process minimises aggregation severity compared to room-temperature or batch methods.
Victoire Laude, Vapourtec Research Scientist, said: “The Vapourtec software interface keeps users informed of each step providing real-time UV and resin volume data, simplifying the process and allowing researchers to focus on optimising reaction conditions and results without manual monitoring.”
For more details, please CLICK HERE.
